Jun Ma PhD.Professor

Publisher:ggwsxyRelease Time:2019-09-13Browse times:519

Jun Ma Professor

Department of Epidemiology and Biostatistics

Email: majun@tmu.edu.cn  

  

Resume

Tianjin “Health (Medical) Statistics” municipal quality course leader, “prominent teacher in Tianjin”. Biostatistics applications and comprehensive evaluation decision-making applications are the main research direction. Research areas include health management, medical insurance, and drug clinical trials. In the China Statistical Education Association, the National Statistical Textbook Review Committee, the China Health Information Society Statistical Theory and Methodology Committee, and the Tianjin Medical Insurance Research Association all held important positions. Participated in the compilation of more than 10 textbooks, of which 2 were editor-in-chief and 3 were deputy editors, and published more than 120 academic papers.

  

Research direction:

The main research directions in recent years are biostatistics applications and comprehensive evaluation decision-making applications.

  

Education background:

1, Sep, 1980 - Jul, 1985, Bachelor of Preventive Medicine, Department of Public Health, Tianjin Medical University;

2. Sep, 1993 - Jul,1996, Master of Epidemiology and Health Statistics, Department of Public Health, Tianjin Medical University;

3. Jul, 2004 – Sep, 2008, Ph.D. of Epidemiology and Health Statistics, Department of Public Health, Tianjin Medical University.

  

Professional Experience:

1. Oct, 2004-present, Professor, Doctoral supervisor (2010), Department of Public Health, Tianjin Medical University;

2, Oct, 1998-Oct, 2004, Associate Professor, Master student supervisor (1999), Department of Public Health, Tianjin Medical University;

3. Oct, 1991-Oct, 1997, Lecturer, Department of Public Health, Tianjin Medical University;

4, Jul, 1987- Oct, 1991, Teaching Assistant, Department of Health, Tianjin Medical University;

5, Jul,1985- Jul, 1987, Counselor, Department of Medical, Tianjin Medical University.

  

Project:

1. Research on cost control of disposable medical materials based on data mining, National Science and Technology Commission Natural Fund, funding: 520,000/520,000 (RMB), Jan, 2014 - Dec, 2017;

2. Blood glucose management compliance platform standard assistant project, enterprises and institutions commissioned projects, funding: 490,000 / 490,000 (RMB), Dec, 2016 – Dec,2018;

3. The second phase of the investigation of blood glucose compliance in large and medium-sized cities in northern China, entrusted projects by enterprises and institutions, funding: 800,000/800,000 (RMB), 2017.2-2018.06.

4. Optimization and evaluation of early myocardial protection strategies in hospital treatment of acute myocardial infarction, enterprises and institutions commissioned projects, funding: 58,000 (RMB), Nov, 2017; Dec, 2020.

5. Prospective multicenter phase 3 clinical study of advanced signet ring cell carcinoma patients receiving standard D2 radical resection and XELOX combined with apatinib adjuvant therapy compared with XELOX program adjuvant therapy, enterprises and institutions commissioned projects, funding: 50,000 (RMB), Nov, 2017 - Dec, 2020.

6. Cities Changing Diabetes - Type 2 Diabetes Education Management Project, Entrusted Projects by Enterprises and Institutions, funding: 2,850,000(RMB), Jan,2018 – Dec, 2020.

Publication

1. Gao, F. , Chen, J. , Liu, X. , Wang, X. , Zhao, H. , Ma, J*et al. (2017). Latent class analysis suggests four classes of persons with type 2 diabetes mellitus based on complications and comorbidities in Tianjin, China: a cross-sectional analysis. Endocrine Journal,64(10), 1007-1016. (IF=2.022)

2. Wang, X. , Chen, J. , Liu, X. , Gao, F. , Zhao, H. , Ma, J*.et al. (2017). Identifying patterns of lifestyle behaviors among people with type 2 diabetes in Tianjin, China: a latent class analysis. Diabetes Therapy. (IF=2.368)

3. Liu, X. , Guo, Y. , Li, D. , Cui, Z. , & Ma, J*. . (2017). The prevalence and long-term variation of hospital readmission for patients with diabetes in tianjin, china: a cross-sectional study. Medicine,96(42), e7953.IF=2.07

4. Liu, XQ., Jing, XY., Chen, JG., Yu, CF; Volkmann, AM., Han, DL., Napier D*., Chen LM*., Ma J*. (2016). Identification of neglected vulnerable   subgroups living with diabetes in Tianjin: a qualitative study. Diabetes-metabolism research and reviews, 32(Supp2). (IF:3.461)

5. Liu, XQ., Chen, JG., Volkmann, AM., Jing, XY., Yu, CF., Li, DD., Chen LM*., Ma J*., Napier D*. (2016). Assessment of diabetes vulnerability in the City Changing   Diabetes (CCD) study in Tianjin. Diabetes-metabolism research and reviews. 32 (Supp2). (IF:3.461

6. Liu, X., Liu, Y., Lv, Y., Li, C., Cui, Z., & Ma, J*. (2015). Prevalence and temporal pattern of hospital readmissions for patients with type I and type II diabetes. BMJ Open,5(11), e007362. (IF:2.669)

7. Jing, X., Huang, C., Zhou, H., Li, C., & Ma, J*. (2015). Association between serum c-reactive protein value and prognosis of patients with non-small cell lung cancer: a meta-analysis. International Journal of Clinical and Experimental Medicine,8(7), 10633-10639. (IF1.277)

8Liu YY, Li CP, Huai MS, Fu XM, Cui Z, Fan LL, Zhang S, Liu Y, Ma J*, Li G*, Shen ZY. (2015). Comprehensive comparison of three different immunosuppressive regimens for   liver transplant patients with hepatocellular carcinoma: steroid-free   immunosuppression induction immunosuppression and standard immunosuppression. Plos One, 10(3): e0120939. (IF:3.335)

9. Hong C, Shen C, Ding H, Huang S, Mu Y, Su H, Wei W, Ma J*, Zheng F*. (2015). An involvement of SR-B1 mediated p38 MAPK   signaling pathway in serum amyloid A-induced angiogenesis in rheumatoid   arthritis. Mol Immunol. 66(2), 340-5. (IF:3.375)

10. Yu   WH, Li CP, Fu XM, Cui Z, Liu XQ, Fan LL, Zhang G, Ma J*. (2014). The Cost-Effectiveness of Different   Feeding Patterns Combined with Prompt Treatments for Preventing   Mother-to-Child HIV Transmission in South Africa: Estimates from Simulation   Modeling. Plos One, 9(7):e102872.IF3.535

11Gu   LL, Liu HL, Fan LL, Lv YJ, Cui Z, Luo Y, Liu YY, Li G*, Li CP*, Ma J*. (2014). Treatment outcomes of   transcatheter arterial chemoembolization combined with local ablative therapy   versus monotherapy in hepatocellular carcinoma: a meta‑analysis. J Cancer Res Clin Oncol, 140:199–210. (IF:3.021)

12Zu YQ, Yang ZY, Tang SS, Han Y, Ma J*. (2014). Effects   of P-Glycoprotein and Its Inhibitors on Apoptosis in K562 Cells. Molecules, 19, 13061-13075. (IF:2.749

13. Liu X, Li C, Gong H, Cui Z, Fan L,Yu W, Zhang C,Ma J*. (2013). An economic evaluation for prevention of diabetes mellitus in a   developing country: a modelling study. BMC Public Health, 1:729. (IF2.746)

14. Li CP, Cui Z, Li SL, Magalhaes RJS, Wang BL, Zhang C, Sun HL, Li CY, Huang LY, Ma J*, Zhang WY*. (2013). Association   between Hemorrhagic Fever with Renal Syndrome Epidemic and Climate Factors in   Heilongjiang Province, China. Am. J. Trop. Med. Hyg, 89(5):1006–1012. (IF:2.740)

15Liu YY, Li CP, Cui Z, Fu XM, Zhang S, Fan LL, Ma J*, Li G*. (2013). The effect of ABCB1 C3435T   polymorphism on pharmacokinetics of    tacrolimus in liver transplantation: A meta-analysis. Gene, 9(9). (IF2.319)

  

Postgraduate training

4 graduated doctoral students, 30 graduated master students, 20 on-job post-graduates students.

Recruits students specialized

1. Doctor of Epidemiology and Health Statistics (Science Degree), Master of Epidemiology and Health Statistics (Science Degree);

2. Master of Applied Statistics (professional degree)

  

Membership of Academic Society

Member of the Fourth Committee of the Health Statistics Committee of the Chinese Preventive Medicine Association;

The 5th Board of Directors of the Chinese Statistical Education Society; Member of the Sixth Committee of the National Statistical Textbook Review Committee;

Member of the Professional Committee of Statistical Theory and Methodology, China Health Information Society;

Member of the Health Statistics Education Committee of China Health Information Society;

Member of the Health Management Statistics Committee of China Health Information Society;

Vice President of Tianjin Medical Insurance Research Association; Executive Director of Tianjin Statistics Association;

Director of Tianjin Preventive Medicine Association;

Deputy Director of the Health Statistics and Information Branch of the Tianjin Preventive Medicine Association., etc.

  

Honors